GLATIRAMER ACETATE INJECTION

GLATIRAMER ACETATE INJECTION was reported 4709 times

GLATIRAMER ACETATE INJECTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ELSBERG SYNDROME 5 0.3846
1 HAEMORRHAGIC ADRENAL INFARCTION 6 0.3750
2 WRONG DEVICE USED 77 0.1174
3 FALLOPIAN TUBE NEOPLASM 2 0.0952
4 CORRECTED TRANSPOSITION OF GREAT VESSELS 2 0.0909
5 AUTONOMIC DYSREFLEXIA 13 0.0802
6 CLINICALLY ISOLATED SYNDROME 4 0.0421
7 DRUG ADMINISTERED IN WRONG DEVICE 40 0.0409
8 PROGRESSIVE RELAPSING MULTIPLE SCLEROSIS 5 0.0403
9 TOXIC NEUROPATHY 13 0.0330
10 RELAPSING-REMITTING MULTIPLE SCLEROSIS 28 0.0324
11 BORDERLINE OVARIAN TUMOUR 2 0.0299
12 RELAPSING MULTIPLE SCLEROSIS 9 0.0298
13 AMNIORRHEXIS 2 0.0278
14 OVARIAN GRANULOSA CELL TUMOUR 2 0.0267
15 MUCOCUTANEOUS LEISHMANIASIS 3 0.0246
16 PREMATURE BABY DEATH 2 0.0244
17 EMBOLIA CUTIS MEDICAMENTOSA 19 0.0239
18 PATERNAL EXPOSURE BEFORE PREGNANCY 7 0.0230
19 ADMINISTRATION SITE INDURATION 2 0.0222
20 MENINGITIS STAPHYLOCOCCAL 3 0.0211
21 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 24 0.0192
22 LACK OF INJECTION SITE ROTATION 28 0.0160
23 HERPES SIMPLEX REACTIVATION 6 0.0157
24 CSF OLIGOCLONAL BAND PRESENT 2 0.0154
25 HERPES ZOSTER REACTIVATION 4 0.0153
26 ADMINISTRATION SITE IRRITATION 2 0.0143
27 INJECTED LIMB MOBILITY DECREASED 2 0.0140
28 TACHYCARDIA PAROXYSMAL 4 0.0138
29 INJECTION SITE NECROSIS 27 0.0132
30 MULTIPLE SCLEROSIS 599 0.0125
31 HIGH RISK PREGNANCY 5 0.0123
32 MULTIPLE SCLEROSIS PSEUDO RELAPSE 4 0.0118
33 ENCEPHALITIS BRAIN STEM 2 0.0116
34 OVARIAN FAILURE 6 0.0112
35 BRAIN SCAN ABNORMAL 6 0.0108
36 LIPOATROPHY 10 0.0105
37 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 19 0.0101
38 IMMEDIATE POST-INJECTION REACTION 11 0.0100
39 INJECTION SITE MASS 351 0.0095
40 URTICARIAL VASCULITIS 5 0.0095
41 JC VIRUS INFECTION 15 0.0094
42 INJECTION SITE INDENTATION 20 0.0092
43 MAGNETIC RESONANCE IMAGING ABNORMAL 11 0.0092
44 PULMONARY NECROSIS 3 0.0088
45 PREMATURE MENOPAUSE 8 0.0087
46 CAUDA EQUINA SYNDROME 6 0.0078
47 MULTIPLE SCLEROSIS RELAPSE 518 0.0076
48 ENCEPHALOMYELITIS 2 0.0073
49 INJECTION SITE ATROPHY 12 0.0073
50 ENTEROCOLITIS BACTERIAL 2 0.0072
51 MUSCLE STRENGTH ABNORMAL 3 0.0072
52 ANAL SPHINCTER ATONY 3 0.0070
53 LACK OF ADMINISTRATION SITE ROTATION 2 0.0066
54 TUNNEL VISION 12 0.0064
55 OESOPHAGEAL ATRESIA 4 0.0064
56 NECROTISING RETINITIS 4 0.0063
57 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS 3 0.0062
58 INJECTION RELATED REACTION 10 0.0061
59 NEUROMYELITIS OPTICA 2 0.0060
60 ADMINISTRATION SITE BRUISE 2 0.0058
61 INJECTION SITE INDURATION 71 0.0055
62 INJECTION SITE SCAR 15 0.0053
63 INJECTION SITE URTICARIA 129 0.0053
64 INJECTION SITE PUSTULE 2 0.0052
65 INJECTION SITE PARAESTHESIA 8 0.0052
66 FAT TISSUE DECREASED 2 0.0051
67 JC POLYOMAVIRUS TEST POSITIVE 6 0.0051
68 PRODUCT SUBSTITUTION 2 0.0050
69 BLADDER DYSFUNCTION 5 0.0049
70 DEVELOPMENTAL HIP DYSPLASIA 4 0.0048
71 PULMONARY VALVE STENOSIS CONGENITAL 2 0.0046
72 PROGRESSIVE MULTIPLE SCLEROSIS 5 0.0043
73 INJECTION SITE CELLULITIS 8 0.0043
74 PROTHROMBIN LEVEL DECREASED 4 0.0043
75 WEST NILE VIRAL INFECTION 3 0.0040
76 MYELITIS 6 0.0039
77 INJURY CORNEAL 2 0.0038
78 INJECTION SITE SWELLING 292 0.0038
79 LIPODYSTROPHY ACQUIRED 8 0.0038
80 MOLLUSCUM CONTAGIOSUM 2 0.0037
81 INJECTION SITE PRURITUS 246 0.0037
82 INJECTION SITE WARMTH 74 0.0036
83 HYPERAMMONAEMIC ENCEPHALOPATHY 6 0.0034
84 RETINAL VASCULAR DISORDER 2 0.0034
85 PARAPARESIS 6 0.0034
86 INJECTION SITE DISCOLOURATION 42 0.0034
87 INFECTIOUS PLEURAL EFFUSION 5 0.0033
88 INJECTION SITE INFLAMMATION 16 0.0032
89 BAND SENSATION 4 0.0032
90 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 26 0.0031
91 INJECTION SITE ERYTHEMA 391 0.0031
92 CEREBELLAR ATAXIA 3 0.0031
93 RENAL SURGERY 2 0.0031
94 IDIOSYNCRATIC DRUG REACTION 3 0.0031
95 INJECTION SITE EXTRAVASATION 37 0.0030
96 ACUTE PROMYELOCYTIC LEUKAEMIA 3 0.0029
97 OPTIC NEURITIS 26 0.0029
98 FACIAL DISCOMFORT 2 0.0028
99 ESCHAR 2 0.0027
100 BRAIN STEM SYNDROME 2 0.0027
101 INJECTION SITE IRRITATION 33 0.0026
102 CROUP INFECTIOUS 2 0.0025
103 OPHTHALMOPLEGIA 4 0.0025
104 SKIN BACTERIAL INFECTION 2 0.0025
105 MATERNAL EXPOSURE DURING BREAST FEEDING 10 0.0025
106 INJECTION SITE REACTION 167 0.0024
107 HYPERTONIC BLADDER 7 0.0024
108 EXPIRED DEVICE USED 8 0.0024
109 QUADRIPARESIS 4 0.0024
110 WALKING DISABILITY 5 0.0024
111 INJECTION SITE DISCOMFORT 25 0.0024
112 FRACTURED COCCYX 3 0.0024
113 INJECTION SITE COLDNESS 2 0.0024
114 INJECTION SITE PAIN 719 0.0023
115 INJECTION SITE OEDEMA 4 0.0023
116 INJECTION SITE VESICLES 14 0.0023
117 INJECTION SITE BRUISING 183 0.0023
118 PERONEAL NERVE PALSY 13 0.0023
119 DEVICE USE ISSUE 40 0.0023
120 AREFLEXIA 6 0.0022
121 MUSCLE NECROSIS 2 0.0022
122 DEVICE MECHANICAL ISSUE 30 0.0022
123 NASAL CAVITY CANCER 2 0.0022
124 BONE CONTUSION 2 0.0022
125 PRODUCT LEAKAGE 12 0.0021
126 INJECTION SITE ULCER 2 0.0021
127 PRODUCT AFTER TASTE 2 0.0021
128 INJECTION SITE HYPOAESTHESIA 3 0.0021
129 INJECTION SITE NODULE 23 0.0021
130 NEEDLE ISSUE 59 0.0020
131 TRIGEMINAL NEURALGIA 8 0.0020
132 MYELOFIBROSIS 6 0.0020
133 CENTRAL NERVOUS SYSTEM LESION 27 0.0020
134 GENITAL HERPES 3 0.0020
135 CORONAVIRUS TEST POSITIVE 2 0.0019
136 INJECTION SITE HYPERSENSITIVITY 6 0.0019
137 CONSCIOUSNESS FLUCTUATING 2 0.0019
138 BURNS THIRD DEGREE 2 0.0019
139 NEUROGENIC BLADDER 4 0.0019
140 OPTIC ATROPHY 3 0.0018
141 FEAR OF INJECTION 13 0.0018
142 ILLUSION 3 0.0018
143 VACCINATION FAILURE 3 0.0018
144 CORNEAL OEDEMA 4 0.0018
145 LYMPHOCYTE COUNT ABNORMAL 2 0.0018
146 SEIZURE LIKE PHENOMENA 3 0.0018
147 MOANING 2 0.0018
148 GLIOBLASTOMA 3 0.0018
149 IMMUNE THROMBOCYTOPENIA 8 0.0017
150 SKIN NECROSIS 9 0.0017
151 PARAPLEGIA 5 0.0017
152 HAEMANGIOMA 4 0.0017
153 SENSE OF OPPRESSION 2 0.0017
154 CORONAVIRUS INFECTION 11 0.0017
155 PULSE ABNORMAL 4 0.0017
156 MONOPARESIS 3 0.0017
157 FEBRILE CONVULSION 2 0.0016
158 PRODUCT SUBSTITUTION ISSUE 94 0.0016
159 POST-ACUTE COVID-19 SYNDROME 2 0.0016
160 HEPATIC NECROSIS 6 0.0016
161 GESTATIONAL HYPERTENSION 2 0.0015
162 PHARYNGEAL SWELLING 15 0.0015
163 INJECTION SITE INFECTION 5 0.0015
164 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 2 0.0015
165 NEAR DEATH EXPERIENCE 5 0.0015
166 CYSTITIS NONINFECTIVE 2 0.0015
167 INJECTION SITE DISCHARGE 8 0.0015
168 LYMPHOPENIA 21 0.0015
169 INJECTION SITE HAEMORRHAGE 118 0.0015
170 MENINGITIS VIRAL 2 0.0015
171 HEAD TITUBATION 2 0.0015
172 CENTRAL NERVOUS SYSTEM LYMPHOMA 2 0.0015
173 IMPAIRED SELF-CARE 3 0.0014
174 VARICELLA ZOSTER VIRUS INFECTION 3 0.0014
175 FLUSHING 147 0.0014
176 ANAL INCONTINENCE 13 0.0014
177 SERUM SICKNESS 4 0.0014
178 SLEEP DEFICIT 3 0.0014
179 LIMB MASS 3 0.0014
180 HEMIPARESIS 23 0.0014
181 APRAXIA 2 0.0013
182 PRODUCT DOSE OMISSION 88 0.0013
183 URINARY TRACT DISORDER 6 0.0013
184 PREMATURE SEPARATION OF PLACENTA 2 0.0013
185 BACTERIAL VAGINOSIS 2 0.0013
186 HEPATITIS E 2 0.0013
187 IDIOPATHIC THROMBOCYTOPENIC PURPURA 2 0.0013
188 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 3 0.0013
189 HISTOPLASMOSIS DISSEMINATED 2 0.0013
190 CEREBRAL ATROPHY 5 0.0013
191 OPTIC NERVE DISORDER 2 0.0012
192 IMMUNOSUPPRESSION 11 0.0012
193 GUILLAIN-BARRE SYNDROME 6 0.0012
194 PANNICULITIS 3 0.0012
195 LIQUID PRODUCT PHYSICAL ISSUE 9 0.0012
196 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 21 0.0012
197 ACUTE PSYCHOSIS 3 0.0012
198 PAPILLOMA VIRAL INFECTION 2 0.0012
199 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
200 INJECTION SITE RASH 37 0.0012
201 INJECTION SITE ABSCESS 3 0.0012
202 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 6 0.0012
203 OLIGOHYDRAMNIOS 4 0.0012
204 FEELING HOT 73 0.0012
205 HYPOAESTHESIA 175 0.0012
206 MENOPAUSE 3 0.0012
207 ACUTE SINUSITIS 2 0.0012
208 HEPATIC LESION 5 0.0012
209 DIPLOPIA 29 0.0011
210 NORMAL NEWBORN 6 0.0011
211 SINUS NODE DYSFUNCTION 2 0.0011
212 OPPORTUNISTIC INFECTION 2 0.0011
213 ARTHRITIS INFECTIVE 5 0.0011
214 HEPATITIS ACUTE 7 0.0011
215 ADENOCARCINOMA OF COLON 2 0.0011
216 DYSGRAPHIA 7 0.0011
217 ABORTION INDUCED 10 0.0011
218 NARCOLEPSY 2 0.0011
219 DEVICE ISSUE 95 0.0011
220 CHILLS 124 0.0011
221 MATERNAL EXPOSURE DURING PREGNANCY 94 0.0011
222 PARALYSIS 15 0.0010
223 ANAPHYLACTIC SHOCK 27 0.0010
224 VITAMIN B12 DECREASED 3 0.0010
225 VOMITING PROJECTILE 3 0.0010
226 LYMPHOPROLIFERATIVE DISORDER 3 0.0010
227 DIPLEGIA 2 0.0010
228 EXPOSURE VIA BREAST MILK 4 0.0010
229 CHEST DISCOMFORT 102 0.0010
230 INTRACRANIAL ANEURYSM 4 0.0010
231 FOAMING AT MOUTH 2 0.0010
232 EAR HAEMORRHAGE 2 0.0010
233 EYE INJURY 3 0.0010
234 MUSCLE CONTRACTURE 2 0.0010
235 GOITRE 4 0.0010
236 MUSCLE SPASTICITY 12 0.0010
237 PRODUCT TEMPERATURE EXCURSION ISSUE 5 0.0010
238 SYRINGE ISSUE 17 0.0010
239 OLIGURIA 6 0.0010
240 FEELING COLD 26 0.0009
241 IMMOBILE 4 0.0009
242 INFECTION SUSCEPTIBILITY INCREASED 2 0.0009
243 ENDOMETRIAL CANCER 2 0.0009
244 OTITIS MEDIA 3 0.0009
245 LIMB DISCOMFORT 28 0.0009
246 CONCUSSION 7 0.0009
247 PRODUCT LOT NUMBER ISSUE 2 0.0009
248 ANXIETY DISORDER 3 0.0009
249 INFECTIOUS MONONUCLEOSIS 2 0.0009
250 THROAT TIGHTNESS 24 0.0009
251 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
252 SCAR 15 0.0009
253 ABORTION SPONTANEOUS 35 0.0009
254 SENSORY LOSS 7 0.0009
255 HYPOPNOEA 3 0.0009
256 HYPOAESTHESIA ORAL 13 0.0009
257 EAR PRURITUS 3 0.0009
258 MUSCLE CONTRACTIONS INVOLUNTARY 3 0.0009
259 SKIN REACTION 12 0.0009
260 DECREASED INTEREST 5 0.0008
261 HEAD DISCOMFORT 15 0.0008
262 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
263 PRODUCT PACKAGING ISSUE 8 0.0008
264 INJURY ASSOCIATED WITH DEVICE 17 0.0008
265 FACIAL BONES FRACTURE 3 0.0008
266 PREMATURE RUPTURE OF MEMBRANES 2 0.0008
267 PRODUCT USE COMPLAINT 13 0.0008
268 FACIAL PARALYSIS 7 0.0008
269 UTERINE LEIOMYOMA 6 0.0008
270 URINARY INCONTINENCE 24 0.0008
271 GAIT INABILITY 27 0.0008
272 BLADDER DISORDER 8 0.0008
273 PALPITATIONS 93 0.0008
274 LOSS OF CONTROL OF LEGS 3 0.0008
275 PURPURA 7 0.0008
276 HOSTILITY 2 0.0008
277 HAEMORRHAGE URINARY TRACT 2 0.0008
278 INSURANCE ISSUE 12 0.0008
279 ABDOMINAL INFECTION 2 0.0008
280 HERPES SIMPLEX 5 0.0008
281 GAIT DISTURBANCE 147 0.0008
282 HEPATITIS TOXIC 2 0.0008
283 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
284 KIDNEY INFECTION 15 0.0008
285 ATAXIA 9 0.0008
286 THERAPY INTERRUPTED 54 0.0008
287 GASTROINTESTINAL STROMAL TUMOUR 2 0.0008
288 BLOOD POTASSIUM ABNORMAL 2 0.0007
289 PRODUCT CLEANING INADEQUATE 2 0.0007
290 GALLBLADDER OPERATION 3 0.0007
291 INVASIVE DUCTAL BREAST CARCINOMA 2 0.0007
292 DRUG-INDUCED LIVER INJURY 23 0.0007
293 ANAPHYLACTOID REACTION 3 0.0007
294 BALANCE DISORDER 63 0.0007
295 DEVICE FAILURE 11 0.0007
296 LIVE BIRTH 6 0.0007
297 ELECTRIC SHOCK SENSATION 2 0.0007
298 MUSCULAR WEAKNESS 81 0.0007
299 PARAESTHESIA 112 0.0007
300 MUSCLE FATIGUE 3 0.0007
301 NECK MASS 2 0.0007
302 INTERVERTEBRAL DISC DISORDER 3 0.0007
303 TENSION HEADACHE 3 0.0007
304 FIBULA FRACTURE 2 0.0007
305 DEVICE DEFECTIVE 12 0.0007
306 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
307 ANAPHYLACTIC REACTION 38 0.0007
308 ABORTION 2 0.0007
309 DYSPHEMIA 3 0.0007
310 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
311 NECK INJURY 2 0.0007
312 GROWTH RETARDATION 2 0.0007
313 MUSCLE TIGHTNESS 11 0.0007
314 ADVERSE REACTION 9 0.0007
315 BRADYKINESIA 4 0.0007
316 FACIAL PAIN 6 0.0007
317 MALIGNANT MELANOMA 9 0.0007
318 PRODUCT DOSE OMISSION ISSUE 197 0.0007
319 INFUSION SITE REACTION 2 0.0007
320 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
321 DYSAESTHESIA 2 0.0007
322 RECTAL CANCER 2 0.0007
323 ECTOPIC PREGNANCY 2 0.0006
324 DIASTOLIC DYSFUNCTION 2 0.0006
325 CHRONIC LYMPHOCYTIC LEUKAEMIA 3 0.0006
326 LOSS OF CONSCIOUSNESS 81 0.0006
327 SARCOIDOSIS 3 0.0006
328 PRE-ECLAMPSIA 3 0.0006
329 GESTATIONAL DIABETES 3 0.0006
330 CYSTITIS 20 0.0006
331 TREMOR 103 0.0006
332 NEURALGIA 15 0.0006
333 MICTURITION URGENCY 7 0.0006
334 SPEECH DISORDER 32 0.0006
335 HEPATOMEGALY 6 0.0006
336 ASPERGILLUS INFECTION 4 0.0006
337 HYPOGAMMAGLOBULINAEMIA 4 0.0006
338 URTICARIA 102 0.0006
339 WALKING AID USER 4 0.0006
340 THERAPY CESSATION 31 0.0006
341 HEMIPLEGIA 5 0.0006
342 HYPOTONIA 6 0.0006
343 COGNITIVE DISORDER 28 0.0006
344 APHASIA 18 0.0006
345 WRONG PRODUCT ADMINISTERED 4 0.0006
346 BODY TEMPERATURE INCREASED 12 0.0006
347 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
348 EAR DISCOMFORT 6 0.0006
349 ANKLE FRACTURE 9 0.0006
350 ORAL PAIN 13 0.0006
351 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
352 ENCEPHALITIS 4 0.0006
353 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 117 0.0006
354 PANIC ATTACK 21 0.0006
355 AUTOIMMUNE HEPATITIS 4 0.0006
356 HYPERREFLEXIA 2 0.0006
357 POST PROCEDURAL COMPLICATION 11 0.0006
358 ERYTHEMA NODOSUM 2 0.0006
359 MOUTH ULCERATION 12 0.0006
360 HANGOVER 2 0.0006
361 FACIAL PARESIS 2 0.0006
362 PRODUCT CONTAMINATION 2 0.0006
363 VISUAL IMPAIRMENT 69 0.0006
364 CHEST PAIN 103 0.0006
365 HOSPITALISATION 85 0.0006
366 URINARY TRACT INFECTION 94 0.0006
367 PREGNANCY 11 0.0005
368 DYSSTASIA 16 0.0005
369 CUTANEOUS VASCULITIS 2 0.0005
370 JAW DISORDER 3 0.0005
371 BRAIN NEOPLASM 5 0.0005
372 BURNING SENSATION 38 0.0005
373 SWELLING FACE 35 0.0005
374 HEART RATE INCREASED 53 0.0005
375 CHRONIC SINUSITIS 2 0.0005
376 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
377 PREMATURE LABOUR 3 0.0005
378 DEVICE LEAKAGE 23 0.0005
379 BOWEL MOVEMENT IRREGULARITY 4 0.0005
380 MOUTH SWELLING 3 0.0005
381 PANIC DISORDER 2 0.0005
382 APHTHOUS ULCER 4 0.0005
383 VASCULITIS 6 0.0005
384 SPINAL PAIN 6 0.0005
385 CERVIX CARCINOMA 2 0.0005
386 COLD SWEAT 9 0.0005
387 SYNCOPE 51 0.0005
388 LYMPHADENOPATHY 18 0.0005
389 COVID-19 89 0.0005
390 HEAD INJURY 16 0.0005
391 INABILITY TO AFFORD MEDICATION 5 0.0005
392 SEIZURE 58 0.0005
393 COORDINATION ABNORMAL 7 0.0005
394 MASS 7 0.0005
395 UTERINE CANCER 4 0.0005
396 INCORRECT DOSE ADMINISTERED BY DEVICE 13 0.0005
397 PRESYNCOPE 12 0.0005
398 FOETAL GROWTH RESTRICTION 3 0.0005
399 HOMICIDAL IDEATION 2 0.0005
400 FALL 164 0.0005
401 MOTOR DYSFUNCTION 5 0.0005
402 DEMYELINATION 2 0.0005
403 INFLUENZA LIKE ILLNESS 40 0.0005
404 PARAESTHESIA ORAL 7 0.0005
405 TEMPERATURE INTOLERANCE 5 0.0005
406 INJECTION SITE HAEMATOMA 7 0.0005
407 TENDERNESS 5 0.0005
408 RENAL PAIN 5 0.0005
409 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
410 THERAPY NON-RESPONDER 21 0.0005
411 MOVEMENT DISORDER 15 0.0005
412 SKIN CANCER 10 0.0005
413 CARDIAC FLUTTER 3 0.0005
414 PRODUCT QUALITY ISSUE 63 0.0005
415 MUSCLE SPASMS 85 0.0005
416 DYSPNOEA 261 0.0005
417 ORAL HERPES 9 0.0005
418 SKIN SWELLING 4 0.0005
419 MONOPLEGIA 2 0.0005
420 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
421 MELANOCYTIC NAEVUS 2 0.0005
422 DEVICE DIFFICULT TO USE 30 0.0005
423 LYMPHOMA 7 0.0005
424 HOT FLUSH 34 0.0005
425 NERVE INJURY 5 0.0004
426 THERAPEUTIC PRODUCT EFFECT DECREASED 20 0.0004
427 SKIN INFECTION 5 0.0004
428 MENINGITIS ASEPTIC 2 0.0004
429 OCULAR DISCOMFORT 5 0.0004
430 ADVERSE DRUG REACTION 40 0.0004
431 CYANOSIS 7 0.0004
432 BACK PAIN 103 0.0004
433 ULCER HAEMORRHAGE 3 0.0004
434 STATUS EPILEPTICUS 5 0.0004
435 HYPERHIDROSIS 57 0.0004
436 PRODUCT LABEL ISSUE 3 0.0004
437 BLINDNESS 18 0.0004
438 PATHOGEN RESISTANCE 4 0.0004
439 EYE MOVEMENT DISORDER 3 0.0004
440 INJECTION SITE PAPULE 2 0.0004
441 PERIPHERAL COLDNESS 6 0.0004
442 SENSORY DISTURBANCE 7 0.0004
443 RESPIRATION ABNORMAL 3 0.0004
444 MUSCLE TWITCHING 10 0.0004
445 CHRONIC MYELOID LEUKAEMIA 2 0.0004
446 CAESAREAN SECTION 5 0.0004
447 MEMORY IMPAIRMENT 59 0.0004
448 FEELING OF DESPAIR 2 0.0004
449 BLINDNESS UNILATERAL 6 0.0004
450 DYSARTHRIA 16 0.0004
451 COVID-19 PNEUMONIA 5 0.0004
452 DIZZINESS 210 0.0004
453 INCORRECT DOSE ADMINISTERED 96 0.0004
454 DEVICE BREAKAGE 17 0.0004
455 ACCIDENT 5 0.0004
456 MACULAR DEGENERATION 5 0.0004
457 PRURITUS GENERALISED 9 0.0004
458 HYPERTHYROIDISM 6 0.0004
459 NEPHROLITHIASIS 19 0.0004
460 RASH VESICULAR 2 0.0004
461 HYPOKINESIA 6 0.0004
462 UNDERDOSE 30 0.0004
463 VERTIGO 25 0.0004
464 JAUNDICE 11 0.0004
465 HYPERSENSITIVITY 75 0.0004
466 CYST 5 0.0004
467 OVARIAN CYST 4 0.0004
468 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
469 ERYSIPELAS 2 0.0004
470 FEELING ABNORMAL 95 0.0004
471 BRAIN OEDEMA 5 0.0004
472 MUSCLE ATROPHY 5 0.0004
473 TASTE DISORDER 8 0.0004
474 HYPERTHERMIA 3 0.0004
475 MUSCULOSKELETAL STIFFNESS 34 0.0004
476 CONGENITAL ANOMALY 3 0.0004
477 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
478 APNOEA 3 0.0004
479 CONTUSION 37 0.0004
480 ANXIETY 109 0.0004
481 HERPES ZOSTER 22 0.0004
482 BEDRIDDEN 5 0.0004
483 ERYTHEMA 78 0.0004
484 NYSTAGMUS 2 0.0004
485 DRUG INEFFECTIVE 496 0.0004
486 HEPATIC STEATOSIS 7 0.0004
487 RETCHING 8 0.0004
488 MENTAL IMPAIRMENT 9 0.0004
489 FRUSTRATION TOLERANCE DECREASED 3 0.0004
490 MUSCLE DISORDER 3 0.0004
491 PAIN IN EXTREMITY 109 0.0004
492 FOOT FRACTURE 7 0.0004
493 POST PROCEDURAL INFECTION 3 0.0004
494 MUSCULOSKELETAL DISORDER 7 0.0004
495 NONSPECIFIC REACTION 2 0.0004
496 ASTHENIA 137 0.0004
497 CEREBRAL HAEMORRHAGE 13 0.0004
498 DEAFNESS UNILATERAL 2 0.0004
499 CHOKING SENSATION 2 0.0004
500 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
501 INJECTION SITE INJURY 2 0.0004
502 DISCOMFORT 22 0.0004
503 LIP SWELLING 12 0.0004
504 ATRIAL SEPTAL DEFECT 3 0.0004
505 WOUND 10 0.0004
506 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
507 CIRCULATORY COLLAPSE 6 0.0004
508 GENERALISED ERYTHEMA 2 0.0004
509 CARDIAC OPERATION 3 0.0003
510 HYPERSOMNIA 10 0.0003
511 MUSCULOSKELETAL DISCOMFORT 6 0.0003
512 MOBILITY DECREASED 25 0.0003
513 BLOOD MAGNESIUM DECREASED 3 0.0003
514 HERPES VIRUS INFECTION 2 0.0003
515 ENTEROCOLITIS 2 0.0003
516 HYPERVENTILATION 2 0.0003
517 NEOPLASM MALIGNANT 23 0.0003
518 GRIP STRENGTH DECREASED 3 0.0003
519 NECK PAIN 19 0.0003
520 LYMPHOCYTE COUNT DECREASED 6 0.0003
521 PLEURISY 2 0.0003
522 KNEE ARTHROPLASTY 7 0.0003
523 THYROID CANCER 4 0.0003
524 FOETAL EXPOSURE DURING PREGNANCY 27 0.0003
525 SWELLING 31 0.0003
526 INGUINAL HERNIA 2 0.0003
527 SKIN DISCOLOURATION 15 0.0003
528 SPINAL OPERATION 4 0.0003
529 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
530 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
531 THINKING ABNORMAL 6 0.0003
532 DEPRESSED MOOD 17 0.0003
533 PRODUCT PRESCRIBING ISSUE 7 0.0003
534 DISEASE PROGRESSION 38 0.0003
535 FLANK PAIN 3 0.0003
536 BRAIN FOG 5 0.0003
537 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
538 PREMATURE DELIVERY 5 0.0003
539 INCREASED APPETITE 6 0.0003
540 VISION BLURRED 43 0.0003
541 ILLNESS 32 0.0003
542 AUTOIMMUNE DISORDER 3 0.0003
543 PARKINSONISM 3 0.0003
544 INFLAMMATORY BOWEL DISEASE 3 0.0003
545 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
546 DISABILITY 6 0.0003
547 LIGAMENT SPRAIN 3 0.0003
548 SARS-COV-2 TEST POSITIVE 4 0.0003
549 SKIN MASS 2 0.0003
550 POST-TRAUMATIC STRESS DISORDER 2 0.0003
551 PRODUCT ADMINISTRATION ERROR 6 0.0003
552 EPILEPSY 9 0.0003
553 FATIGUE 229 0.0003
554 DRUG EXPOSURE DURING PREGNANCY 10 0.0003
555 TREATMENT NONCOMPLIANCE 16 0.0003
556 PARANOIA 5 0.0003
557 LYMPHOEDEMA 2 0.0003
558 DIVERTICULITIS 8 0.0003
559 FIBROMYALGIA 7 0.0003
560 ORTHOSTATIC HYPOTENSION 5 0.0003
561 WEIGHT FLUCTUATION 3 0.0003
562 EXTRASYSTOLES 2 0.0003
563 DEFAECATION URGENCY 2 0.0003
564 ENCEPHALOPATHY 7 0.0003
565 CONFUSIONAL STATE 46 0.0003
566 HALLUCINATION, VISUAL 6 0.0003
567 SKIN IRRITATION 13 0.0003
568 HAND FRACTURE 2 0.0003
569 HEADACHE 176 0.0003
570 LEUKOPENIA 14 0.0003
571 LETHARGY 16 0.0003
572 PANIC REACTION 2 0.0003
573 LEUKOCYTOSIS 5 0.0003
574 BIPOLAR DISORDER 3 0.0003
575 PRODUCT DISPENSING ERROR 6 0.0003
576 STAPHYLOCOCCAL INFECTION 9 0.0003
577 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
578 MIGRAINE 26 0.0003
579 PAIN 167 0.0003
580 PYREXIA 94 0.0003
581 SENSITIVE SKIN 2 0.0003
582 PSYCHIATRIC SYMPTOM 2 0.0003
583 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 13 0.0003
584 DEVICE MALFUNCTION 19 0.0003
585 CEREBRAL DISORDER 2 0.0003
586 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
587 FEELING DRUNK 2 0.0003
588 EYE SWELLING 10 0.0003
589 RESPIRATORY TRACT INFECTION 7 0.0003
590 DEPRESSION 61 0.0003
591 HEPATIC FUNCTION ABNORMAL 10 0.0003
592 EYE INFECTION 3 0.0003
593 INTESTINAL OBSTRUCTION 10 0.0003
594 MITRAL VALVE INCOMPETENCE 3 0.0003
595 PEMPHIGOID 2 0.0003
596 PRODUCT AVAILABILITY ISSUE 6 0.0003
597 ABDOMINAL DISCOMFORT 44 0.0003
598 TINNITUS 12 0.0003
599 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
600 NEOPLASM 3 0.0003
601 LOWER LIMB FRACTURE 5 0.0003
602 CONDITION AGGRAVATED 79 0.0003
603 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
604 ATRIOVENTRICULAR BLOCK 2 0.0003
605 CELLULITIS 13 0.0003
606 LIMB INJURY 7 0.0003
607 EAR PAIN 5 0.0003
608 GASTROINTESTINAL DISORDER 23 0.0003
609 BASAL CELL CARCINOMA 4 0.0003
610 CHOKING 5 0.0003
611 SWOLLEN TONGUE 8 0.0003
612 DEVICE DELIVERY SYSTEM ISSUE 7 0.0003
613 SKIN LESION 7 0.0003
614 RESPIRATORY ARREST 7 0.0003
615 SINUS DISORDER 5 0.0003
616 PNEUMOTHORAX 4 0.0003
617 LOW BIRTH WEIGHT BABY 2 0.0003
618 ULCER 4 0.0003
619 INFLUENZA 28 0.0003
620 ABSCESS 4 0.0003
621 WRIST FRACTURE 3 0.0003
622 WEIGHT INCREASED 56 0.0002
623 ANGIOEDEMA 11 0.0002
624 RHINITIS 2 0.0002
625 NAUSEA 195 0.0002
626 COLITIS ULCERATIVE 11 0.0002
627 DYSKINESIA 10 0.0002
628 AMNESIA 16 0.0002
629 DECUBITUS ULCER 2 0.0002
630 EYE DISORDER 8 0.0002
631 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
632 FUNGAL INFECTION 8 0.0002
633 EOSINOPHIL COUNT INCREASED 2 0.0002
634 DYSPHONIA 14 0.0002
635 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 17 0.0002
636 COLITIS 9 0.0002
637 FACE OEDEMA 4 0.0002
638 INFECTION 34 0.0002
639 JOINT INJURY 5 0.0002
640 ROTATOR CUFF SYNDROME 3 0.0002
641 DRUG RESISTANCE 6 0.0002
642 NASOPHARYNGITIS 43 0.0002
643 RASH GENERALISED 6 0.0002
644 NEUROPATHY PERIPHERAL 22 0.0002
645 MUSCLE STRAIN 2 0.0002
646 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
647 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
648 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
649 PRODUCT STORAGE ERROR 20 0.0002
650 ORAL CANDIDIASIS 3 0.0002
651 IMMUNE SYSTEM DISORDER 3 0.0002
652 TOOTH INFECTION 3 0.0002
653 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 41 0.0002
654 DYSMENORRHOEA 3 0.0002
655 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
656 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
657 GASTROENTERITIS VIRAL 4 0.0002
658 OROPHARYNGEAL DISCOMFORT 2 0.0002
659 LIP DRY 2 0.0002
660 RESTLESS LEGS SYNDROME 4 0.0002
661 RETINAL DETACHMENT 2 0.0002
662 OVARIAN CANCER 2 0.0002
663 MALAISE 95 0.0002
664 ORAL DISCOMFORT 3 0.0002
665 POLLAKIURIA 9 0.0002
666 APHONIA 3 0.0002
667 DEMENTIA 6 0.0002
668 BACTERIAL INFECTION 4 0.0002
669 CARPAL TUNNEL SYNDROME 3 0.0002
670 APPENDICITIS 2 0.0002
671 DIARRHOEA HAEMORRHAGIC 2 0.0002
672 LEUKAEMIA 2 0.0002
673 PAIN IN JAW 6 0.0002
674 THROMBOSIS 17 0.0002
675 VOMITING 99 0.0002
676 PROTEINURIA 4 0.0002
677 VIRAL INFECTION 7 0.0002
678 URINARY RETENTION 7 0.0002
679 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
680 EXPOSURE DURING PREGNANCY 13 0.0002
681 IMPAIRED QUALITY OF LIFE 3 0.0002
682 PULMONARY FIBROSIS 4 0.0002
683 PRURITUS 80 0.0002
684 AFFECT LABILITY 2 0.0002
685 MYELODYSPLASTIC SYNDROME 3 0.0002
686 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
687 SURGERY 12 0.0002
688 ASCITES 6 0.0002
689 COELIAC DISEASE 2 0.0002
690 MENORRHAGIA 4 0.0002
691 HOSPICE CARE 2 0.0002
692 DYSGEUSIA 15 0.0002
693 THROAT IRRITATION 9 0.0002
694 RASH MACULAR 7 0.0002
695 BRAIN INJURY 2 0.0002
696 HEART RATE DECREASED 7 0.0002
697 HEPATIC FAILURE 6 0.0002
698 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
699 SOMNOLENCE 40 0.0002
700 BLOOD PRESSURE INCREASED 30 0.0002
701 HIP ARTHROPLASTY 3 0.0002
702 DELUSION 3 0.0002
703 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 9 0.0002
704 NERVOUS SYSTEM DISORDER 6 0.0002
705 NERVOUSNESS 10 0.0002
706 WEIGHT DECREASED 53 0.0002
707 SCRATCH 2 0.0002
708 MOOD SWINGS 6 0.0002
709 MYALGIA 32 0.0002
710 SCIATICA 3 0.0002
711 EAR INFECTION 5 0.0002
712 EATING DISORDER 4 0.0002
713 HIP FRACTURE 6 0.0002
714 BREAST CANCER METASTATIC 2 0.0002
715 FEAR 5 0.0002
716 SUICIDAL IDEATION 17 0.0002
717 DECREASED ACTIVITY 2 0.0002
718 BLOOD BILIRUBIN INCREASED 5 0.0002
719 MENSTRUATION DELAYED 2 0.0002
720 BACK DISORDER 3 0.0002
721 BACK INJURY 2 0.0002
722 PALLOR 5 0.0002
723 IMPAIRED HEALING 6 0.0002
724 GASTROINTESTINAL PAIN 2 0.0002
725 VISUAL ACUITY REDUCED 6 0.0002
726 FOOT DEFORMITY 2 0.0002
727 ABDOMINAL PAIN UPPER 37 0.0002
728 DYSPHAGIA 17 0.0002
729 OXYGEN SATURATION DECREASED 10 0.0002
730 EYE PAIN 10 0.0002
731 CHROMATURIA 4 0.0002
732 HEART RATE IRREGULAR 4 0.0002
733 DRUG INTOLERANCE 17 0.0002
734 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
735 MYOCARDIAL ISCHAEMIA 2 0.0002
736 INTENTIONAL DOSE OMISSION 5 0.0002
737 SCAB 2 0.0002
738 ACCIDENTAL EXPOSURE TO PRODUCT 18 0.0002
739 SHOCK 4 0.0002
740 AMENORRHOEA 3 0.0002
741 METASTASES TO LIVER 3 0.0002
742 DISEASE RECURRENCE 8 0.0002
743 PRODUCT PRESCRIBING ERROR 4 0.0002
744 THIRST 3 0.0002
745 ROAD TRAFFIC ACCIDENT 7 0.0002
746 RASH PRURITIC 9 0.0002
747 HEPATITIS C 2 0.0002
748 LOCALISED INFECTION 4 0.0002
749 PELVIC PAIN 3 0.0002
750 NOCTURIA 2 0.0002
751 HYPERCALCAEMIA 2 0.0002
752 SEPSIS 18 0.0002
753 BREAST CANCER 15 0.0002
754 ILEUS 2 0.0002
755 PHOTOPHOBIA 3 0.0002
756 CEREBROVASCULAR ACCIDENT 27 0.0002
757 DERMATITIS ALLERGIC 2 0.0002
758 RASH 69 0.0002
759 BLOOD URINE PRESENT 3 0.0002
760 ALOPECIA 31 0.0002
761 INSOMNIA 42 0.0002
762 TACHYCARDIA 14 0.0002
763 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
764 SLEEP DISORDER 11 0.0002
765 HYPERTENSION 33 0.0002
766 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
767 INFLAMMATION 8 0.0002
768 PNEUMONIA 50 0.0002
769 DEAFNESS 4 0.0002
770 PULMONARY CONGESTION 2 0.0002
771 BLOOD PRESSURE ABNORMAL 3 0.0002
772 ABDOMINAL PAIN 35 0.0002
773 DEHYDRATION 20 0.0001
774 SKIN DISORDER 5 0.0001
775 EYE HAEMORRHAGE 2 0.0001
776 COUGH 42 0.0001
777 QUALITY OF LIFE DECREASED 2 0.0001
778 ANGER 5 0.0001
779 PRODUCT TASTE ABNORMAL 2 0.0001
780 SINUSITIS 15 0.0001
781 ACUTE HEPATIC FAILURE 2 0.0001
782 RIB FRACTURE 3 0.0001
783 GASTRIC DISORDER 5 0.0001
784 ARTHRALGIA 60 0.0001
785 ABDOMINAL DISTENSION 15 0.0001
786 LUNG DISORDER 7 0.0001
787 PERIPHERAL SWELLING 22 0.0001
788 BLOOD TEST ABNORMAL 2 0.0001
789 ADVERSE EVENT 13 0.0001
790 OROPHARYNGEAL PAIN 13 0.0001
791 CARDIOGENIC SHOCK 2 0.0001
792 HYPOACUSIS 6 0.0001
793 DRUG INTERACTION 22 0.0001
794 FAECES DISCOLOURED 3 0.0001
795 GASTROENTERITIS 2 0.0001
796 PULMONARY EMBOLISM 13 0.0001
797 DYSURIA 5 0.0001
798 PSYCHOTIC DISORDER 4 0.0001
799 TOOTH DISORDER 3 0.0001
800 HEPATOTOXICITY 3 0.0001
801 PULMONARY MASS 2 0.0001
802 IMMUNODEFICIENCY 2 0.0001
803 GLOSSODYNIA 3 0.0001
804 MUSCULOSKELETAL PAIN 7 0.0001
805 PREMATURE BABY 4 0.0001
806 HEPATIC ENZYME INCREASED 9 0.0001
807 OSTEOPENIA 2 0.0001
808 ILL-DEFINED DISORDER 8 0.0001
809 DEVICE RELATED INFECTION 2 0.0001
810 RENAL DISORDER 6 0.0001
811 MENINGIOMA 2 0.0001
812 DISORIENTATION 5 0.0001
813 MYOCARDIAL INFARCTION 22 0.0001
814 ARTHROPATHY 7 0.0001
815 INTENTIONAL PRODUCT MISUSE 11 0.0001
816 HYPOTHYROIDISM 4 0.0001
817 HYPONATRAEMIA 7 0.0001
818 NIGHT SWEATS 4 0.0001
819 DRY MOUTH 10 0.0001
820 CEREBRAL INFARCTION 3 0.0001
821 PRODUCT USE ISSUE 23 0.0001
822 CHOLELITHIASIS 4 0.0001
823 METASTASES TO BONE 2 0.0001
824 OSTEONECROSIS 4 0.0001
825 MANIA 2 0.0001
826 EXPIRED PRODUCT ADMINISTERED 4 0.0001
827 ABDOMINAL PAIN LOWER 3 0.0001
828 CANDIDA INFECTION 2 0.0001
829 HAEMATEMESIS 3 0.0001
830 DIABETES MELLITUS 9 0.0001
831 OSTEOARTHRITIS 5 0.0001
832 HEPATITIS 3 0.0001
833 UNRESPONSIVE TO STIMULI 3 0.0001
834 SKIN ULCER 3 0.0001
835 HAEMATOMA 3 0.0001
836 DEVICE USE ERROR 4 0.0001
837 PLEURAL EFFUSION 7 0.0001
838 DRUG DOSE OMISSION 19 0.0001
839 DRUG DOSE OMISSION BY DEVICE 9 0.0001
840 SEDATION 3 0.0001
841 ARTHRITIS 9 0.0001
842 ANHEDONIA 3 0.0001
843 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
844 GASTRITIS 3 0.0001
845 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
846 MENSTRUATION IRREGULAR 3 0.0001
847 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
848 OSTEOMYELITIS 2 0.0001
849 CONSTIPATION 24 0.0001
850 BONE DISORDER 2 0.0001
851 HAEMATOCHEZIA 6 0.0001
852 RESPIRATORY DISTRESS 3 0.0001
853 OFF LABEL USE 95 0.0001
854 DIARRHOEA 70 0.0001
855 MENTAL STATUS CHANGES 3 0.0001
856 MEDICATION ERROR 6 0.0001
857 CONJUNCTIVITIS 2 0.0001
858 EPISTAXIS 8 0.0001
859 CARDIAC DISORDER 10 0.0001
860 OEDEMA PERIPHERAL 13 0.0001
861 HEPATIC CIRRHOSIS 2 0.0001
862 BLOOD SODIUM DECREASED 2 0.0001
863 INFUSION RELATED REACTION 7 0.0001
864 OCULAR HYPERAEMIA 5 0.0001
865 GASTRIC ULCER 2 0.0001
866 RASH ERYTHEMATOUS 5 0.0001
867 CHOLESTASIS 2 0.0001
868 GLAUCOMA 2 0.0001
869 HERNIA 2 0.0001
870 ERUCTATION 2 0.0001
871 DECREASED APPETITE 24 0.0001
872 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
873 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
874 BLOOD POTASSIUM DECREASED 3 0.0001
875 INJURY 7 0.0001
876 NO ADVERSE EVENT 18 0.0001
877 FULL BLOOD COUNT DECREASED 2 0.0001
878 RENAL FAILURE 13 0.0001
879 SKIN EXFOLIATION 8 0.0001
880 BRONCHITIS 7 0.0001
881 IRRITABLE BOWEL SYNDROME 2 0.0001
882 HALLUCINATION 7 0.0001
883 VAGINAL HAEMORRHAGE 4 0.0001
884 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
885 APPLICATION SITE PAIN 2 0.0001
886 BLOOD PRESSURE DECREASED 6 0.0001
887 LIVER DISORDER 4 0.0001
888 RASH PAPULAR 2 0.0001
889 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
890 NEUTROPENIA 12 0.0001
891 HAEMATURIA 3 0.0001
892 HYPOKALAEMIA 4 0.0001
893 HAEMORRHAGE 9 0.0001
894 DEATH 73 0.0001
895 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
896 WHEEZING 5 0.0001
897 BLOOD PRESSURE FLUCTUATION 2 0.0001
898 IRRITABILITY 5 0.0001
899 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
900 CRYING 3 0.0001
901 THERAPEUTIC RESPONSE DECREASED 5 0.0001
902 RESPIRATORY FAILURE 6 0.0001
903 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
904 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
905 CARDIOVASCULAR DISORDER 2 0.0001
906 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
907 EXPOSURE VIA SKIN CONTACT 2 0.0001
908 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
909 PANCREATITIS 4 0.0001
910 BRADYCARDIA 4 0.0001
911 CARDIAC FAILURE 6 0.0001
912 CARDIAC FAILURE CONGESTIVE 6 0.0001
913 PAIN OF SKIN 2 0.0001
914 DRUG EFFECT DECREASED 4 0.0001
915 EXTRA DOSE ADMINISTERED 3 0.0001
916 FREQUENT BOWEL MOVEMENTS 2 0.0001
917 PSORIATIC ARTHROPATHY 3 0.0001
918 MOOD ALTERED 2 0.0001
919 PRODUCT USE IN UNAPPROVED INDICATION 18 0.0001
920 TREATMENT FAILURE 6 0.0001
921 BLISTER 4 0.0001
922 DYSPEPSIA 7 0.0001
923 RED BLOOD CELL COUNT DECREASED 2 0.0001
924 CONVULSION 4 0.0001
925 SEPTIC SHOCK 3 0.0001
926 MENTAL DISORDER 3 0.0001
927 LIVER FUNCTION TEST ABNORMAL 2 0.0001
928 LABORATORY TEST ABNORMAL 2 0.0001
929 PULMONARY OEDEMA 3 0.0001
930 RESPIRATORY DISORDER 2 0.0001
931 LACRIMATION INCREASED 2 0.0001
932 EMOTIONAL DISORDER 2 0.0001
933 FEMUR FRACTURE 2 0.0001
934 ARRHYTHMIA 3 0.0001
935 COMA 3 0.0001
936 RENAL CANCER 3 0.0001
937 ASTHMA 7 0.0001
938 FEBRILE NEUTROPENIA 4 0.0001
939 DRY EYE 3 0.0001
940 AGGRESSION 3 0.0001
941 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
942 HYPOTENSION 12 0.0001
943 EYE PRURITUS 2 0.0001
944 FLUID RETENTION 3 0.0001
945 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
946 ECZEMA 3 0.0001
947 HYPOXIA 2 0.0001
948 PRODUCT ADHESION ISSUE 2 0.0001
949 SKIN BURNING SENSATION 4 0.0001
950 DISTURBANCE IN ATTENTION 3 0.0001
951 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
952 OEDEMA 3 0.0001
953 C-REACTIVE PROTEIN INCREASED 2 0.0001
954 RESTLESSNESS 2 0.0001
955 UNEVALUABLE EVENT 4 0.0001
956 DRY SKIN 7 0.0001
957 PLASMA CELL MYELOMA 2 0.0001
958 BONE PAIN 3 0.0001
959 NASAL CONGESTION 3 0.0001
960 ABNORMAL BEHAVIOUR 2 0.0001
961 CATARACT 3 0.0001
962 JOINT SWELLING 6 0.0000
963 HAEMOGLOBIN DECREASED 5 0.0000
964 OSTEOPOROSIS 2 0.0000
965 CARDIAC ARREST 4 0.0000
966 CARDIO-RESPIRATORY ARREST 2 0.0000
967 RENAL IMPAIRMENT 4 0.0000
968 RENAL FAILURE ACUTE 2 0.0000
969 RHINORRHOEA 3 0.0000
970 BLOOD CHOLESTEROL INCREASED 2 0.0000
971 PRODUCTIVE COUGH 2 0.0000
972 BLOOD GLUCOSE DECREASED 2 0.0000
973 HYPOGLYCAEMIA 2 0.0000
974 ATRIAL FIBRILLATION 4 0.0000
975 AGITATION 3 0.0000
976 CHRONIC KIDNEY DISEASE 3 0.0000
977 PSORIASIS 5 0.0000
978 PROSTATE CANCER 3 0.0000
979 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
980 ANAEMIA 7 0.0000
981 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
982 COMPLETED SUICIDE 3 0.0000
983 PANCYTOPENIA 2 0.0000
984 FLATULENCE 2 0.0000
985 EYE IRRITATION 2 0.0000
986 BLADDER CANCER 2 0.0000
987 EMOTIONAL DISTRESS 4 0.0000
988 DRUG ABUSE 2 0.0000
989 DRUG WITHDRAWAL SYNDROME 2 0.0000
990 OVERDOSE 4 0.0000
991 TOXICITY TO VARIOUS AGENTS 3 0.0000
992 BLOOD GLUCOSE INCREASED 2 0.0000